Kura Oncology Inc (KURA)
20.59
+0.31
(+1.53%)
USD |
NASDAQ |
May 02, 16:00
20.59
0.00 (0.00%)
After-Hours: 19:03
Kura Oncology Max Drawdown (5Y): 81.79% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 81.79% |
March 31, 2024 | 81.79% |
February 29, 2024 | 81.79% |
January 31, 2024 | 81.79% |
December 31, 2023 | 81.79% |
November 30, 2023 | 81.79% |
October 31, 2023 | 81.79% |
September 30, 2023 | 79.72% |
August 31, 2023 | 76.89% |
July 31, 2023 | 76.89% |
June 30, 2023 | 76.89% |
May 31, 2023 | 76.89% |
April 30, 2023 | 76.89% |
March 31, 2023 | 74.27% |
February 28, 2023 | 74.27% |
January 31, 2023 | 74.27% |
December 31, 2022 | 74.27% |
November 30, 2022 | 74.27% |
October 31, 2022 | 74.27% |
September 30, 2022 | 74.27% |
August 31, 2022 | 74.27% |
July 31, 2022 | 74.27% |
June 30, 2022 | 74.27% |
May 31, 2022 | 74.27% |
April 30, 2022 | 72.44% |
Date | Value |
---|---|
March 31, 2022 | 72.44% |
February 28, 2022 | 72.44% |
January 31, 2022 | 72.44% |
December 31, 2021 | 72.44% |
November 30, 2021 | 72.44% |
October 31, 2021 | 72.44% |
September 30, 2021 | 72.44% |
August 31, 2021 | 72.44% |
July 31, 2021 | 72.44% |
June 30, 2021 | 72.44% |
May 31, 2021 | 72.44% |
April 30, 2021 | 78.58% |
March 31, 2021 | 78.58% |
February 28, 2021 | 78.58% |
January 31, 2021 | 78.58% |
December 31, 2020 | 78.58% |
November 30, 2020 | 78.58% |
October 31, 2020 | 78.58% |
September 30, 2020 | 78.58% |
August 31, 2020 | 78.58% |
July 31, 2020 | 78.58% |
June 30, 2020 | 78.58% |
May 31, 2020 | 78.58% |
April 30, 2020 | 78.58% |
March 31, 2020 | 78.58% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
72.44%
Minimum
May 2021
81.79%
Maximum
Oct 2023
76.81%
Average
78.58%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Tivic Health Systems Inc | -- |
AIM ImmunoTech Inc | 99.76% |
Perspective Therapeutics Inc | 91.70% |
Protalix BioTherapeutics Inc | 94.35% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -6.665 |
Beta (5Y) | 0.8918 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 65.05% |
Historical Sharpe Ratio (5Y) | 0.0503 |
Historical Sortino (5Y) | 0.1221 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.35% |